Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Collapse
Brand Logo

Forum

  1. Home
  2. PAAB Q&A
  3. DTCA/I, consumer secondary audience
  4. Consumer-facing Institutional Messages
PAAB Notice
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.

Consumer-facing Institutional Messages

Scheduled Pinned Locked Moved DTCA/I, consumer secondary audience
2 Posts 2 Posters 549 Views
  • Oldest to Newest
  • Newest to Oldest
  • Most Votes
Reply
  • Reply as topic
Log in to reply
This topic has been deleted. Only users with topic management privileges can see it.
  • M Offline
    M Offline
    matt.s17
    wrote on last edited by
    #1

    Hello! We are working on developing a consumer-facing institutional message campaign with our clients. The objective of this campaign is to reiterate the aspiration of our client—Company X—in being committed to curing/ending suffering from Condition Y. Our client’s portfolio includes multiple treatments for Condition Y as well as other diseases. Messaging on these APS might include statements like "We all play a role in ending the suffering caused by Condition Y. Forever." or "Company X, together with the healthcare community, is committed to putting an end to Condition Y." The banners and/or posters associated with this message would directly link to videos which highlight Company X’s commitment in supporting healthcare institutions that treat Condition Y. Given that this campaign would not explicitly highlight one treatment in particular and does not include a help-seeking message, we are hoping to gather the PAAB’s opinion on the degree of pre-clearance that would be needed for this type of communication.

    Jennifer CarrollJ 1 Reply Last reply
    0
    • M matt.s17

      Hello! We are working on developing a consumer-facing institutional message campaign with our clients. The objective of this campaign is to reiterate the aspiration of our client—Company X—in being committed to curing/ending suffering from Condition Y. Our client’s portfolio includes multiple treatments for Condition Y as well as other diseases. Messaging on these APS might include statements like "We all play a role in ending the suffering caused by Condition Y. Forever." or "Company X, together with the healthcare community, is committed to putting an end to Condition Y." The banners and/or posters associated with this message would directly link to videos which highlight Company X’s commitment in supporting healthcare institutions that treat Condition Y. Given that this campaign would not explicitly highlight one treatment in particular and does not include a help-seeking message, we are hoping to gather the PAAB’s opinion on the degree of pre-clearance that would be needed for this type of communication.

      Jennifer CarrollJ Offline
      Jennifer CarrollJ Offline
      Jennifer Carroll
      wrote on last edited by
      #2

      Hello @matt-s17

      The Distinction Between Advertising and Other Activities states:

      An institutional message is defined as a communication (e.g., brochure, published article, prospectus, annual report, etc.), which provides information about a pharmaceutical manufacturer, or other institution, concerning its philosophy, activities, product range (by name), financial details, area of future development or research, etc. Such a message may be a nonpromotional activity in the following circumstances:

      • the purpose of the communication is clearly to provide information about the institution rather than about the drugs being marketed, developed or researched,
      • information about the drugs being marketed, developed or researched is limited to the name and therapeutic use of the drug, and
      • no emphasis is given to any one or more products, or their benefits

      The activity described above seems to place emphasis on a particular therapeutic area and class of products which the sponsor has a vested interest and therefore would fall in the scope of advertising. If the intent is for the messages mentioned above to exist in the consumer space and be targeted at consumers only, it would be subject to consumer advertising regulations and an advisory opinion may be provided by PAAB, AdStandards or sent directly to Health Canada. If there is a possibility that the message/campaign will be targeted at HCPs in any way, it would be subject to the PAAB Code and should be reviewed by PAAB.

      1 Reply Last reply
      0
      Reply
      • Reply as topic
      Log in to reply
      • Oldest to Newest
      • Newest to Oldest
      • Most Votes


      • Login

      • Don't have an account? Register

      • Login or register to search.
      • First post
        Last post
      0
      • Categories
      • Recent
      • Tags
      • Popular
      • Users
      • Groups